Sylvain Ursuegui

Sylvain Ursuegui

Auto-generated profile, based on publicly available information

Sylvain Ursuegui

Stilla Technologies, Biopark 1, Mail du Professeur Georges Mathé, 94800, Villejuif, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2017 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
IDIgor Dovgan
Igor Dovgan
SUSylvain Ursuegui
Sylvain Ursuegui
SEStéphane Erb
Stéphane Erb
CMChloé Michel
Chloé Michel
SKSergii Kolodych
Sergii Kolodych
AWAlain Wagner
Alain Wagner

1 February 2018 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
IDIgor Dovgan
Igor Dovgan
SEStéphane Erb
Stéphane Erb
SHSteve Hessmann
Steve Hessmann
SUSylvain Ursuegui
Sylvain Ursuegui
CMChloé Michel
Chloé Michel
AWAlain Wagner
Alain Wagner
Here, we introduce 4-azidophenyl glyoxal (APG) as an efficient plug-and-play reagent for the selective functionalisation of arginine residues in native antibodies. The selective reaction between APG and arginines’ guanidine groups allowed a facile introduction of azide groups on the monoclonal antibody trastuzumab (plug stage). These pre-functionalised antibody–azide conjugates were then derivatised during the “play stage” via a biorthogonal cycloaddition reaction with different strained alkynes. This afforded antibody-fluorophore and antibody–oligonucleotide conjugates, all showing preserved antigen selectivity and high stability in human plasma. Due to a lower content of arginines compared to lysines in native antibodies, this approach is thus attractive for the preparation of more homogeneous conjugates. This method proved to be orthogonal to classical lysine-based conjugation and allowed straightforward generation of dual-payload antibody.

2 January 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
IDIgor Dovgan
Igor Dovgan
AHAlexandre Hentz
Alexandre Hentz
OKOleksandr Koniev
Oleksandr Koniev
AEAnthony Ehkirch
Anthony Ehkirch
SHSteve Hessmann
Steve Hessmann
AWAlain Wagner
Alain Wagner
Controlled protein functionalization holds great promise for a wide variety of applications. However, despite intensive research, the stoichiometry of the functionalization reaction remains difficult to control due to the inherent stochasticity of the conjugation process. Classical approaches that exploit peculiar structural features of specific protein substrates, or introduce reactive handles via mutagenesis, are by essence limited in scope or require substantial protein reengineering. We herein present equimolar native chemical tagging (ENACT), which precisely controls the stoichiometry of inherently random conjugation reactions by combining iterative low-conversion chemical modification, process automation, and bioorthogonal trans-tagging. We discuss the broad applicability of this conjugation process to a variety of protein substrates and payloads.

20 November 2024 in Analytica Chimica Acta
Verified
Journal Article
Open access
FBFlorence Busato
Florence Busato
SUSylvain Ursuegui
Sylvain Ursuegui
JDJean-François Deleuze
Jean-François Deleuze
Jorg TostJorg Tost
Jorg Tost
MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression. They have attracted significant interest as biomarkers for early diagnosis, prediction and monitoring of treatment response in many diseases. As individual miRNAs often lack the required sensitivity and specificity, miRNA signatures are developed for clinical applications. Digital PCR (dPCR) is a sensitive fluorescent-based quantification method, that can be used to detect the expression of miRNAs in patient samples. Our study presents the first proof-of-concept of a multiplexed dPCR assay for the simultaneous analysis and quantification of multiple miRNAs. After reverse transcription (RT) using a pool of miRNA-specific stem-loop primers, dPCR was performed with a universal reverse primer and miRNA-specific forward primers along with fluorescently-labelled hydrolysis probes. Multiple experimental parameters were evaluated and strategies for modulating the observed signals were devised. The optimised assay was applied to the analysis of miRNAs from cell lines and biological samples. Although absolute quantification was lost, due to the reverse transcription step, quantification was linear for the dilution series and results were highly reproducible for independent dPCR and RT reactions. Our results confirmed the high sensitivity of dPCR for patient samples. We demonstrate the feasibility and reliability of multiplexed detection and quantification of miRNAs by dPCR that can be applied in a clinical setting to evaluate miRNA signatures.

7 April 2014 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SUS. Ursuegui
S. Ursuegui
NCN. Chivot
N. Chivot
SMS. Moutin
S. Moutin
ABA. Burr
A. Burr
CFC. Fossey
C. Fossey
ALA. Laurent
A. Laurent
An isatoic anhydride derivative, bearing a biotin and a disulfide linker, was specifically designed for separation of nucleic acids by a selective 2′-hydroxyl acylation of RNA.

19 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SUSylvain Ursuegui
Sylvain Ursuegui
MRMarion Recher
Marion Recher
WKWojciech Krężel
Wojciech Krężel
AWAlain Wagner
Alain Wagner
Drugs, usually long acting and metabolically stable molecules, might be the source of adverse effects triggered by complex drug interactions, anaphylaxis and drug-induced coagulopathy. To circumvent this growing drug safety issue, we herein investigate the opportunity offered by bio-orthogonal chemistry for in vivo drug neutralization. We design a small-molecule anticoagulant drug (Warfarin) containing an azide group that acts as a safety pin. It allows drug deactivation and restoration of physiological coagulation via in vivo click reaction with a suitable cyclooctyne-based neutralizing agent. In this strategy, the new molecule formed by reaction of the drug and the antidote is deprived of biological activity and prone to fast renal clearance. This ‘Click & Clear’ approach lays ground for new strategies in designing drugs with switchable biophysical properties.